WO2023222332 - DIPHENYL UREAS FOR THE TREATMENT OF VIRAL INFECTIONS
National phase entry is expected:
Publication Number
WO/2023/222332
Publication Date
23.11.2023
International Application No.
PCT/EP2023/060613
International Filing Date
24.04.2023
Title **
[English]
DIPHENYL UREAS FOR THE TREATMENT OF VIRAL INFECTIONS
[French]
URÉES DE DIPHÉNYLE POUR LE TRAITEMENT D'INFECTIONS VIRALES
Applicants **
MERCK PATENT GMBH
Inventors
BETZ, Ulrich
LINDEMANN, Sven
Priority Data
22173527.7
16.05.2022
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2231 | |
| EPO | Filing, Examination, Granting | 9670 | |
| Japan | Filing, Examination, Granting | 2272 | |
| South Korea | Filing, Examination, Granting | 2277 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
21,190
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention encompasses diphenyl urea selected but not limited from the group of compounds 1 -7 for use in the treatment of virus and coronavirus infections, including COVID-19, alone or in combination with one or more additional therapeutic agents.[French]
La présente invention concerne une urée de diphényle sélectionnée, mais sans s'y limiter, dans le groupe des composés 1-7 pour une utilisation dans le traitement d'infections virales et à coronavirus, y compris la COVID-19, seule ou en combinaison avec un ou plusieurs agents thérapeutiques supplémentaires.